Supervalu on Friday announced it will host the 2015 National Expo this August in St. Paul, Minn. This year’s event will take place from Aug. 11-13 at the RiverCentre in downtown St. Paul and is open to the more than 2,000 independent retail customers served by Supervalu, as well as hundreds of vendors and industry professionals.
Zipnosis, which provides patient access to mainstream medicine via online diagnosis and the treatment of common health needs, has announced that its services are now available in 11 states across the country.
Pharmacist’s Ultimate Health of St. Paul, Minn., and its president, Stephen J. Poindexter, have been barred from distributing any "unapproved new drugs" that the company had distributed under the guise that they were dietary supplements.
UltiMed’s UltiCare Micro 4mm x 32G pen needle is its shortest, thinnest pen needle, according to the company, which also said the needle provides a more comfortable injection for patients living with diabetes.
3M on Wednesday announced that reality star Ryan Sutter has signed on as spokesman for Ace Brand beginning with the launch of the Ace Brand Champion Challenge, which runs from July 11 through Sept. 10.
Historical Remedies, based in St. Paul, Minn., last week launched a line of six homeopathic "stress reduction" lozenges for introduction into the food, drug and mass channel at the ECRM Vitamin, Diet & Sports Nutrition EPPS in Atlanta.
Diabetes patients who adhere to their medication therapies have a significantly lower risk of hospitalization, according to a new study scheduled for presentation this week at the Academy of Managed Care Pharmacy’s 23rd annual meeting and showcase in Minneapolis.
A letter educating healthcare providers regarding a drug-drug interaction between prescription anticlotting drug Plavix (clopidogrel) and a proton-pump inhibitor has resulted in a reduction in the number of patients combining the two therapies, according to a new study by Prime Therapeutics released Monday.
A point-of-sale safety check may reduce the risk of patients unsafely receiving a drug for Type 2 diabetes that may increase their risk of heart attack, according to a new study conducted by pharmacy benefit manager Prime Therapeutics and scheduled for presentation at the 23rd annual meeting of the Academy of Managed Care Pharmacy in Minneapolis.